Peer-reviewedCC BYFrontiers in medicine16 Oct 2026

The liver–muscle axis in metabolic dysfunction-associated steatotic liver disease: a narrative review and conceptual framework for body-composition phenotyping

Zhendong Ma¹
Xinri Zhang¹
Yan Leng²
Xingyu Chen²

¹College of Traditional Chinese Medicine, Changchun University of Traditional Chinese Medicine , , ,
²Department of Liver, Spleen and Gastroenterology, Affiliated Hospital of Changchun University of Traditional Chinese Medicine , , ,

Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) : A systematic review and meta-analysis
Mohammed Alfawaz, Dareen Bajamaan, Lama Alghamdi +7
Medicine23 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Functional and Metabolic Correlates of Age- and Sex-Normalized Handgrip Strength in Children with Metabolic Dysfunction-Associated Steatotic Liver Disease
Mohit Kehar, Carolina Jimenez-Rivera, Leah Feret +3
Journal of clinical medicine27 Sep 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Neurological manifestations in metabolic dysfunction syndrome are associated with cumulative metabolic burden beyond hyperglycaemia: a translational study
Jinfang Ma, Yi Tang, Qingxing Xie +8
Frontiers in endocrinology16 Oct 2026Peer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC
Efficacy of plant extracts for metabolic dysfunction-associated steatotic liver disease: a network meta-analysis
Zhenghong Xie, Tianxing Chen
Frontiers in pharmacology16 Oct 2026Peer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
Tirzepatide use in adolescents with metabolic dysfunction‐associated steatotic liver disease (MASLD): A case series
Brandon J. Perumpail, Andrea Tou, Jennifer Panganiban
JPGN reports12 Oct 2026Peer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC

Cite

BibTeX

@article{ma2026livermuscle,
  title = {{The liver–muscle axis in metabolic dysfunction-associated steatotic liver disease: a narrative review and conceptual framework for body-composition phenotyping}},
  author = {Zhendong Ma and Xinri Zhang and Yan Leng and Xingyu Chen},
  journal = {Frontiers in medicine},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13655384},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - The liver–muscle axis in metabolic dysfunction-associated steatotic liver disease: a narrative review and conceptual framework for body-composition phenotyping
AU  - Zhendong Ma
AU  - Xinri Zhang
AU  - Yan Leng
AU  - Xingyu Chen
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in medicine
UR  - https://europepmc.org/article/PMC/PMC13655384
SN  - 2296-858X
ER  -

Related

Cite